Michael Benkowitz is PRESIDENT AND COO of UNITED THERAPEUTICS Corp. Currently has a direct ownership of 2,577 shares of UTHR, which is worth approximately $937,126. The most recent transaction as insider was on Sep 14, 2021, when has been sold 4,000 shares (Common Stock) at a price of $208.47 per share, resulting in proceeds of $833,880. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.58K
0% 3M change
9.52% 12M change
Total Value Held $937,126

MICHAEL BENKOWITZ Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 14 2021
SELL
Sale (or disposition) back to the issuer
$833,880 $208.47 p/Share
4,000 Reduced 64.15%
2,235 Common Stock
Sep 14 2021
BUY
Exercise of conversion of derivative security
$215,320 $53.83 p/Share
4,000 Added 39.08%
6,235 Common Stock
Sep 09 2021
SELL
Sale (or disposition) back to the issuer
$843,560 $210.89 p/Share
4,000 Reduced 64.15%
2,235 Common Stock
Sep 09 2021
BUY
Exercise of conversion of derivative security
$215,320 $53.83 p/Share
4,000 Added 39.08%
6,235 Common Stock
Sep 07 2021
SELL
Sale (or disposition) back to the issuer
$831,920 $207.98 p/Share
4,000 Reduced 64.15%
2,235 Common Stock
Sep 07 2021
BUY
Exercise of conversion of derivative security
$215,320 $53.83 p/Share
4,000 Added 39.08%
6,235 Common Stock
Sep 02 2021
SELL
Sale (or disposition) back to the issuer
$849,240 $212.31 p/Share
4,000 Reduced 64.15%
2,235 Common Stock
Sep 02 2021
BUY
Exercise of conversion of derivative security
$215,320 $53.83 p/Share
4,000 Added 39.08%
6,235 Common Stock
Aug 31 2021
SELL
Sale (or disposition) back to the issuer
$859,520 $214.88 p/Share
4,000 Reduced 64.15%
2,235 Common Stock
Aug 31 2021
BUY
Exercise of conversion of derivative security
$215,320 $53.83 p/Share
4,000 Added 39.08%
6,235 Common Stock
Aug 26 2021
SELL
Sale (or disposition) back to the issuer
$823,000 $205.75 p/Share
4,000 Reduced 64.15%
2,235 Common Stock
Aug 26 2021
BUY
Exercise of conversion of derivative security
$215,320 $53.83 p/Share
4,000 Added 39.08%
6,235 Common Stock
Aug 24 2021
SELL
Sale (or disposition) back to the issuer
$822,200 $205.55 p/Share
4,000 Reduced 64.15%
2,235 Common Stock
Aug 24 2021
BUY
Exercise of conversion of derivative security
$215,320 $53.83 p/Share
4,000 Added 39.08%
6,235 Common Stock
Aug 19 2021
SELL
Sale (or disposition) back to the issuer
$804,200 $201.05 p/Share
4,000 Reduced 64.15%
2,235 Common Stock
Aug 19 2021
BUY
Exercise of conversion of derivative security
$215,320 $53.83 p/Share
4,000 Added 39.08%
6,235 Common Stock
Aug 17 2021
SELL
Sale (or disposition) back to the issuer
$814,960 $203.74 p/Share
4,000 Reduced 64.15%
2,235 Common Stock
Aug 17 2021
BUY
Exercise of conversion of derivative security
$215,320 $53.83 p/Share
4,000 Added 39.08%
6,235 Common Stock
Aug 12 2021
SELL
Sale (or disposition) back to the issuer
$812,200 $203.05 p/Share
4,000 Reduced 64.15%
2,235 Common Stock
Aug 12 2021
BUY
Exercise of conversion of derivative security
$215,320 $53.83 p/Share
4,000 Added 39.08%
6,235 Common Stock
Aug 10 2021
SELL
Sale (or disposition) back to the issuer
$817,360 $204.34 p/Share
4,000 Reduced 64.15%
2,235 Common Stock
Aug 10 2021
BUY
Exercise of conversion of derivative security
$215,320 $53.83 p/Share
4,000 Added 39.08%
6,235 Common Stock
Aug 05 2021
SELL
Sale (or disposition) back to the issuer
$821,680 $205.42 p/Share
4,000 Reduced 64.15%
2,235 Common Stock
Aug 05 2021
BUY
Exercise of conversion of derivative security
$215,320 $53.83 p/Share
4,000 Added 39.08%
6,235 Common Stock
Nov 02 2020
SELL
Sale (or disposition) back to the issuer
$3,778,236 $133.98 p/Share
28,200 Reduced 93.38%
1,998 Common Stock
MB

Michael Benkowitz

PRESIDENT AND COO
Silver Spring, MD

Track Institutional and Insider Activities on UTHR

Follow UNITED THERAPEUTICS Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTHR shares.

Notify only if

Insider Trading

Get notified when an United Therapeutics Corp insider buys or sells UTHR shares.

Notify only if

News

Receive news related to UNITED THERAPEUTICS Corp

Track Activities on UTHR